Revolutionizing Thrombolytic Therapy for Better Lives
Therapeutic Applications
Our research focuses on treating major thrombotic conditions, including:
Ischemic Stroke
Occlusion of cerebral arteries due to thrombus formation, leading to reduced cerebral perfusion and neuronal injury.
Deep Vein Thrombosis (DVT)
Formation of thrombi within the deep venous system, most commonly in the lower extremities.
Myocardial Infarction
Acute coronary artery occlusion resulting in ischemia and necrosis of cardiac tissue.
Pulmonary Embolism (PE)
Obstruction of pulmonary arteries by embolized thrombi, impairing pulmonary circulation and gas exchange.
Preclinical Development & Clinical Readiness
A key objective of our program is to identify a preclinical candidate (PCC) suitable for Phase 1 clinical trials.
Our long-term development plan includes progressing into clinical evaluation through Phase 2 SBIR-supported programs.
Our Mission
Transforming Thrombolytic Therapy for Better Patient Outcomes
Our mission is to create safe and effective thrombolytic therapeutics that reduce complications, save lives, and advance treatment options for patients affected by serious thrombotic diseases.